ppt bang ucup
TRANSCRIPT
-
7/28/2019 Ppt Bang Ucup
1/34
Trial of Labor After Previous
Cesarean DeliveryTOLAC
The term trial of labor refers to a trial of labor in women who
have
had a previous cesarean delivery, regardless of the outcome.
TOLAC MAY LEAD TO SUCCESFUL VBAC
-
7/28/2019 Ppt Bang Ucup
2/34
ACOG # 115 2010
Validate/Reference well performed studies & present
a range of data (+/-) emphasizing that it may be
reasonable to expand the CANDIDATE POOL.
Extreme caution should STILL be exercised whenconsidering additional factors @ term which may
influence the success or failure of VBAC
THE MOST CLINICALLY USEFUL INFORMATION IN THE
NEW BULLETIN
TOLAC COUNSELING CALCULATOR
MORTALITY /MORBIDITY % tge TABLES
-
7/28/2019 Ppt Bang Ucup
3/34
The American College of Obstetricians and Gynecologists
guidelines for identifying women who are potential candidates
for TOLAC NOW include the following:
WHO ARE NEW TOLAC CANDIDATES TWO previous low transverse uterine incisions Ok Twins Ok ECV Ok EGA > 40 weeks Ok One Low vertical Ok
Suspected Macrosomia alone Ok
Informed induction Ok however NO prostaglandins
followed by oxytocin. ( Foley bulb followed by pitocin )
Undocumented scar with out history suggesting classical c/s
ACOG PRACTICE BULLETIN AUGUST Number 115, 2010
-
7/28/2019 Ppt Bang Ucup
4/34
Contraindications for VBAC Prior classical or T-shaped uterine incision or extensive
transfundal uterine surgery (eg, myomectomy)
Previous uterine rupture (the frequency of repeat rupturevaries from 6 to 32 percent, respectively if the lower uterinesegment or the upper segment was the site of the initialrupture)
No Cytotec
Medical or obstetrical complications that preclude vaginal birth(eg, placenta previa)
Inability to immediately perform emergency cesarean deliverydue to factors related to the facility, surgeon, anesthesia, ornursing staff
Two or more prior uterine scars and no prior vaginaldeliveries. 2010 REMOVED two previous c/s andremained silent regarding previous vaginal delivery
ACOG VBAC Bulletin # 54JULY 2004/ 2010 #115
-
7/28/2019 Ppt Bang Ucup
5/34
Uterine Rupture
By Incision Location
The rate of rupture reported by incision
location is:
Classical (4 to 9 %)
T-shaped (4 to 9 %)
Low vertical (1 to 7 %)
1 Low transverse ( 0.7 to 0.9 %)2 Low transverse ( 0.9-1.8 % )
-
7/28/2019 Ppt Bang Ucup
6/34
2 previous C/S
Candidates but Counsel Carefully
Two large studies referenced by ACOG, with sufficient size to control for
confounding variables, reported on the risks for women with two previous
cesarean deliveries undergoing TOLAC.
One study found no increased risk of uterine rupture (0.9% versus 0.7%) in
women with one versus multiple prior cesarean deliveries , whereas the
other noted a risk of Uterine Rupturethat increased from 0.9% to 1.8% (
2X )in women with one versus two prior cesarean deliveries
Both studies reported some increased risk in morbidity among women
with more than one prior cesarean delivery although the absolute
magnitude of the difference in these risks was relatively small (eg, 2.1%
versus 3.2%) composite major morbidity in one study
-
7/28/2019 Ppt Bang Ucup
7/34
2 PREVIOUS C/S
ACOG 2010
The chance ofachieving VBAC appears to be similarfor women with one or more than one cesareandelivery.
Given the overall data, it is reasonable to consider
women with two previous low transverse cesareandeliveries to be candidates for TOLAC
Do Not forget to Counsel based on the
combination of other factors that affect theprobability of achieving a successful VBAC.
-
7/28/2019 Ppt Bang Ucup
8/34
Maternal Factors Associated
VBAC SUCCESS Young maternal age
Increased height
Body mass index
-
7/28/2019 Ppt Bang Ucup
9/34
-
7/28/2019 Ppt Bang Ucup
10/34
TOLAC/VBAC SUCCESS COUNSELING
CALCULATOR 2010 ACOG A model was developed specifically for women
undergoing TOLAC at term with one prior low
transverse cesarean delivery incision, singletonpregnancy, and cephalic fetal presentation.
This model may have utility for patient
education and counseling for those consideringTOLAC at term
-
7/28/2019 Ppt Bang Ucup
11/34
VAGINAL BIRTH AFTER CESAREAN
Height & weight optional; enter them to automatically calculate BMI
Maternal age
Height (range 54-80 in.)
Weight (range 80-310 lb.)
Body mass index (BMI, range
15-75)
African-American?
Hispanic?
Any previous vaginal delivery?
Any vaginal delivery sincelast cesarean?
Indication for prior cesarean
of arrest
of dilation or descent?
-
7/28/2019 Ppt Bang Ucup
12/34
SAMPLE PATIENT
5 FOOT 3 INCHES
225 LBS
HISPANIC
NO PREVIOUS VAGINAL DELIVERY
PREVIOUS C/S FOR CPD
Predicted chance of vaginal birth aftercesarean: 24.5% 95% CI: [21.3%, 28.1%]
-
7/28/2019 Ppt Bang Ucup
13/34
CONSIDER THE RESULTS
Consider additional Information
It is designed for educational use and is based on a
population of women who received care at the
hospitals within the MFMU Network. Responsibility
for its correct application is accepted by the enduser.
"Development of a nomogram for prediction of
vaginal birth after cesarean delivery," Obstetrics andGynecology, volume 109, pages 806-12, 2007.
-
7/28/2019 Ppt Bang Ucup
14/34
ACOG/TOLAC CALCULATOR
ACOG 2010
Although there is no universally agreed ondiscriminatory point, evidence suggests thatwomen with at least
6070% chance of VBAC Have equal or less maternal morbidity when they
undergo TOLAC than women undergoing elective
repeat cesarean delivery
-
7/28/2019 Ppt Bang Ucup
15/34
ACOG/TOLAC CALCULATOR
ACOG 2010
Less than or Equal to 60%
probability TOLAC RISK outweighthe potential benefit Failed VBAC is associated with a greater
chance of NEONATAL AND MATERNALMORBIDITY than woman undergoing elective
repeat cesarean delivery
-
7/28/2019 Ppt Bang Ucup
16/34
The MFMU Cesarean Registry:Prospective study with > 14,500 vbac attempts
The overall VBAC success rate in obesewomen (BMI > or = 30) was lower (68.4%)than in non obese women (79.6%) (P < .001)
When combined with induction and lack ofprevious vaginal delivery, successful VBACoccurred in only 44.2% of cases.
Am J Obstet Gynecol 2005 Sep;193(3 Pt 2):1016-23
-
7/28/2019 Ppt Bang Ucup
17/34
Success for VBAC by History
PREVIOUS VAGINAL DELIVERY
Yes / 85% success No / 60% success
PREVIOUS VBAC DELIVERY
Yes / 85% success No / 65% success
CERVIX 4 CM ON ADMISSION
Yes / 85 % success No / 65% success
SPONTANEOUS LABOR 80% success
Am J Obstet Gynecol 2005; 193:1016
-
7/28/2019 Ppt Bang Ucup
18/34
Success for VBAC by history
Previous non recurring indication 75-85 %
All pts with DYSTOCIA as indication 50-80%
Latent phase C/S (4cm or less) 80%Active phase C/S ( 5 to 9 cm ) 70%
Second stage C/S (10 & pushing) 10%
ACOG VBAC BULLETIN # 54 2004
-
7/28/2019 Ppt Bang Ucup
19/34
Increase BMI > 39 = Increased risk
A BMI > 39 was associated with greater compositematernal morbidity and neonatal injury comparedwith elective repeat cesarean delivery
Increasing BMI was directly associated with failedtrial of labor after previous cesarean delivery
BMI > 39 TOLAC WAS ASSOCIATED WITH
5 X risk of uterine rupture (2.1% vs 0.4%),
5 X risk of neonatal injury (1.1% vs 0.2%) 2 X risk of Maternal Morbidity (7.2% versus 3.8%)
Obstet Gynecol. 2006 Jul;108(1):125-33 MFMU
-
7/28/2019 Ppt Bang Ucup
20/34
VBAC Safety and Success
AT OR
Beyond 40 weeks of gestation
There is a 4% increased risk for a failed VBAC
@ 35 % @ 41 weeks vs 31 % @ 40 weeks
~ 65 % successful VBAC @ 41 weeks
The risk of overall maternal morbidity IS not
clinically or statistically significant when
comparing after 41 vs 40 weeks (2.7% @ 41
weeks compared with 2.1% @ 40 0/7 weeks).
Obstet Gynecol. 2005 Oct;106(4):700-6
-
7/28/2019 Ppt Bang Ucup
21/34
40 WEEKS OR GREATER
Although chances of success may be lower( 4%) in
more advanced gestations, gestational age of greater
than 40 weeks alone should not preclude TOLAC.
Use calculator to help you decide Be cautious and include OTHER PERTINENT risk
factors for VBAC failure or increased risk for uterine
rupture with TOLAC in this situation such as
Interdelivery interval, EFW ( > 3600 grams) , & Bishop
score, Previous C/S indication,
ACOG 2010 #115
-
7/28/2019 Ppt Bang Ucup
22/34
4000 GRAMS MACROSOMIA
Some limited evidence also suggests that the uterine
rupture rate is increased (relative risk 2.3, P
-
7/28/2019 Ppt Bang Ucup
23/34
TWINS
Women with twin gestations had a similar chance of achieving
VBAC as women with singleton gestations and did not incur
any greater risk of uterine rupture or maternal or perinatal
morbidity.
Women with one previous cesarean delivery with a low
transverse incision, who are otherwise appropriate candidates
for twin vaginal delivery, may be considered candidates for
TOLAC.
-
7/28/2019 Ppt Bang Ucup
24/34
INDUCTION/AUGMENTATION
Induced labor is less likely to result in VBAC than
spontaneous labor, ESPECIALLY with an unfavorable cervix.
Therefore, selecting women most likely to give birth vaginally
while avoiding sequential use of prostaglandins and
oxytocin appears to have the lowest risks of uterine rupture.
The varying outcomes of available studies and small absolute
magnitude of the risk reported in those studies support that
oxytocinaugmentation may be used in patients undergoing
TOLAC. 1% risk of rupture with oxytocin augmentation
Induction utilizing mechanical dilation ( Foley Bulb distended
to 40 ml more effective or @ least as effective as Cytotec in
RCT) may be an option for TOLAC candidates with an
unfavorable cervix.
-
7/28/2019 Ppt Bang Ucup
25/34
COUNSELING RISK OF
UTERINE RUPTURE
Spontaneous labor 0.9% 1 c/s vs 1.8% for 2
Induced TOLAC 1% - 2.4%
Pitocin Augmented 1%
Am J Obstet Gynecol 1999;181:882
N Engl J Med 2004;351:2581 9
N Engl J Med. 2001 Jul 5;345(1):3-8.
ACOG Number 115, August 2010
-
7/28/2019 Ppt Bang Ucup
26/34
IS THERE A role of UTERINE CLOSURE
in the risk of uterine rupture
NOT CONSISTENTLY DEMONSTARTED AS A RISK FACTOR ANDNOT INCLUDED BY ACOG AS A RISK FACTOR
Prior single-layer closure may be associated with a
two fold or higher risk of uterine rupture comparedwith double-layer closure. Single-layer closure should
be avoided in women who could contemplate future
vaginal birth after cesarean delivery.
Bujold E Obstet Gynecol. 2010 Jul;116(1):43-50
Bujold E Am J Obstet Gynecol. 2002;186(6):1326-30
-
7/28/2019 Ppt Bang Ucup
27/34
Controversy Regarding
Closure of the Uterus
Only one Author (Bujold E) has demonstrated anincreased risk of uterine rupture with single vs two layer
closure in two separate retrospective studies.
No proven physiologic/biologic models. Inclusion ofendometrium in animal studies may be associated with
adenomyosis and interfere with scar formation ; However
Never been demonstrated to effect scar integrity.
Hypoxia and/Or vascular occlusion may result in poor tissue
healing? Locking vs Running uterine closure? Or Multiple
hemostatic figure of 8 sutures? Never been demonstrated to
effect scar integrity .
Sh t I t d li I t l
-
7/28/2019 Ppt Bang Ucup
28/34
Short Interdelivery IntervalTime elapsed from previous delivery date to
current TOLAC
Multiple studies have demonstrated that an
Interdelivery interval < or = to 18 months may be
associated with a two fold or higher risk of uterine
rupture during TOLAC. Furthermore it appears that ashorter Interdelivery interval is associated with a
greater than two fold risk of rupture.
Obstet Gynecol. 2010 May;115(5):1003-6Obstet Gynecol. 2007 Nov;110(5):1075-82.
Am J Obstet Gynecol. 2002 ;187(5):1199-202
Obstet Gynecol. 2001 Feb;97(2):175-7
Am J Obstet Gynecol 2000;183:1180
1183
-
7/28/2019 Ppt Bang Ucup
29/34
If Uterine Rupture Occurs with
Immediately Available Team
Risk of HIE 10-11% @ worse case estimate
(95% confidence interval, 1.810.6%)
Neonatal death ~ 5% @ worse case estimate(95% CI, 04.2% )
Maternal risk of ~ 10 % for Transfusion
5% risk for TAH ;
30 % for TAH with Catastrophic Rupture
ACOG Number 115, August 2010
N Engl J Med 2001;345:3-8
-
7/28/2019 Ppt Bang Ucup
30/34
Maternal Risks ERCD (%) TOLAC (%)
One CD Two CDs
Endometritis 1.52.1 2.9 3.1
Operative injury 0.42.6 0.4 0.4
Blood transfusion 11.4 0.71.7 3.2
Hysterectomy 00.4 0.20.5 0.6
Uterine rupture 0.40.5 0.70.9 0.91.8
Maternal death 0.020.04 0.02 0
ACOG Number 115, August 2010
-
7/28/2019 Ppt Bang Ucup
31/34
Neonatal risk
Short term respiratory transitional needs ~ 2 x as high
with ERCD vs successful VBAC
Hyperbilirubinemia ~ 2 x as high with ERCD vs
successful VBAC
Neonatal morbidity is higher in the setting of a failed
TOLAC than with successful VBAC
( therefore < 60% success not recommended for TOLAC) Perinatal mortality is higher( includes stillbirth) with TOLAC
vs ERCD ; however the absolute risk is ~ 1/10 of 1%ACOG Number 115, August 2010
N Engl J Med 2004;351:25819
-
7/28/2019 Ppt Bang Ucup
32/34
Neonatal Risks ERCD (%) TOLAC (%)
IUFD 3738 weeks 0.08 0.38
IUFD 39 weeks or greater 0.01 0.16
HIE 0013 0.08
Neonatal death 0.05 0.08 NS
Perinatal death 0.01 0.13 HYPOXIA
Neonatal admission 6.0 6.6 NS
Respiratory morbidity 1
5 0.1
1.8
Transient tachypnea 6.2 3.5
Hyperbilirubinemia 5.8 2.2
-
7/28/2019 Ppt Bang Ucup
33/34
DOCUMENTATION MANDATORY
Documentation of counseling and the management plan
should be included in the medical record.
Potential benefits and risks( % ) of both TOLAC and elective
repeat cesarean delivery should be discussed and
documented.
The VBAC SUCCESS CALCULATOR AND MATERNAL /NEONATAL
RISK TABLES provided by ACOG facilitate a STANDARDIZED
discussion that is patient specific and ENDORSED by ACOG.
After counseling, the ultimate decision to undergo TOLAC or
a repeat cesarean delivery should be made by the patient in
consultation with her healthcare provider.
Dr Montgomery Recommends
-
7/28/2019 Ppt Bang Ucup
34/34
Dr Montgomery Recommends DOCUMENT COUNSELING WIH QUOTED RISK/BENEFIT % tges
TOLAC CALCULATOR : No < 60 /60-69 Offer/ 70 or > Recommend
Additionally consider interdelivery interval during antenatal calculation
DO RECOMMEND For a patient who has requested TOLAC a scheduledrepeat cesarean section by 41 0/7 weeks with success calculated @ 70%For a patient who has requested TOLAC a scheduled repeat cesareansection by 40 0/7 weeks with success calculated @ < 70%
REMEMBER EFW & modified Bishop Score as you approach 38 weeks
Thoroughly counsel about induction or augmentation taking into accountadditional factors associated with failure and/or increased risk.
DO RECOMMEND SCHEDULED REPEAT CESAREAN SECTION @ 39 WEEKSFOR PATIENTS WHO DECLINE TOLAC; Due to the documented increasedrisk of IUFD after 39 weeks.
DO NOT recommend TOLAC for patients with a history of failure ofdescent (previously dilated to 10 cm) >/= to 85 % will have a failed VBACSchedule C/S @ 39 0/7 weeks for these patients.
DO NOT recommend TOLAC For patients with a BMI of 39 or greater.Schedule C/S @ 39 0/7 weeks for these patients.